Whipple Procedure (Pancreaticoduodenectomy): A complex surgery removing the head of the pancreas, part of the small intestine, gallbladder, and sometimes part of the stomach to treat pancreatic cancer.
In many cases, the entire stomach can be preserved (sparing the pylorus), which may lead to better long-term nutritional outcomes and reduced "dumping syndrome" compared to a classic Whipple
Vascular Assessment: A critical component of the modern Whipple is the assessment of the Superior Mesenteric Vein (SMV) and Portal Vein. As noted in your next section, involvement of these vessels no longer precludes surgery but requires advanced vascular reconstruction skills.
Faster Recovery: Patients often return to their daily routines and "normal life" much quicker than with the traditional open approach.
Shorter Hospital Stay: The minimally invasive nature typically allows patients to go home several days earlier.
Reduced Pain & Scarring: Smaller "keyhole" incisions lead to significantly less postoperative pain, less need for narcotics, and minimal scarring.
Enhanced Precision: Surgeons use 3D high-definition views and "wristed" robotic tools that provide better stability and range of motion for delicate suturing.
Lower Complication Rates: The technique is associated with less blood loss and a lower risk of wound-related infections or hernias after surgery.
Removal of the tail and/or body of the pancreas, is the standard treatment for tumors located in these regions. It can be done robotically in most cases.
Splenic Preservation (Warshaw Technique or Vessel Preservation): For benign or low-grade lesions, the spleen can often be preserved to maintain its immune and hematologic functions.
Distal Pancreatectomy with Splenectomy: In cases of malignancy, the spleen and its associated lymph nodes are typically removed to ensure a comprehensive oncologic resection.
While surgeons generally prefer to save as much of the organ as possible (parenchyma-sparing), a total pancreatectomy is sometimes necessary for patients with multifocal disease or high-risk genetic predispositions.
Indications: Typically reserved for widespread pancreatic cancer (IPMN involving the entire duct), familial pancreatic cancer syndromes, or chronic pancreatitis where all other treatments have failed.
Post-Operative Management: Because the pancreas is responsible for both insulin production and digestive enzymes, this procedure results in "brittle diabetes" (Type 3c) and permanent pancreatic exocrine insufficiency.
Advanced Care: Patients require lifelong insulin therapy and pancreatic enzyme replacement therapy (PERT) to manage digestion and blood glucose levels.
This parenchyma-sparing technique designed for benign or low-grade neoplasms located specifically in the neck or mid-body of the pancreas.
Organ Preservation: Unlike a distal pancreatectomy, which removes the entire tail of the pancreas, this procedure only removes the diseased central segment. By preserving the pancreatic head and tail, we maximize the preservation of both endocrine (insulin) and exocrine (digestive enzyme) function.
This approach significantly reduces the long-term risk of new-onset diabetes and digestive malabsorption compared to more extensive resections.
Surgical removal of infected or symptomatic dead pancreatic tissue (necrosis) following a severe episode of necrotizing pancreatitis. My practice prioritizes the Surgical Step-Up Approach: This evidence-based strategy aims to control infection and remove debris with the least invasive method possible:
Phase 1: Percutaneous Catheter Drainage (PCD) A drain is inserted—typically through the left retroperitoneal space—using imaging guidance. This initial step often successfully mitigates sepsis and, in some cases, may completely resolve the collection without the need for further surgery.
Phase 2: Video-Assisted Retroperitoneal Debridement (VARD) If drainage alone is insufficient, a minimally invasive VARD is performed. A small 5 cm subcostal incision is made, following the path of the previously placed drain into the retroperitoneal space.
The primary goal is to alleviate the debilitating pain associated with chronic pancreatitis by relieving the high pressure within the ductal system. It is most effective when the main pancreatic duct is significantly dilated (typically >6 mm in diameter).
Functional Preservation: Because no pancreatic tissue is removed, this is a parenchyma-sparing operation, meaning it does not typically worsen pre-existing diabetes or malabsorption.
Unlike the Puestow, which only drains the duct, the Frey procedure involves "coring out" the diseased, fibrotic tissue from the head of the pancreas. This is followed by a longitudinal opening of the main pancreatic duct and a side-to-side anastomosis to the jejunum.
The Clinical Advantage: By removing the "pacemaker" of pain (the inflammatory head) while preserving the pancreatic parenchyma, this procedure offers superior pain relief for patients whose disease is localized primarily in the head of the organ.
Organ Preservation: Because the duodenum and the back of the pancreatic head are left intact, it is significantly less invasive than a Whipple procedure, leading to lower complication rates and a better quality of life post-operatively.
Pancreatic enucleation is a targeted, parenchyma-sparing technique used for small, well-circumscribed, and usually benign or low-grade tumors (such as Insulinomas or small Non-functional Neuroendocrine Tumors). The tumor must be located away from the main pancreatic duct (typically a distance of >2–3 mm) to minimize the risk of a post-operative ductal injury.
Surgical Precision: We often utilize Intraoperative Ultrasound (IOUS) during the procedure to precisely map the tumor's relationship to the pancreatic duct and nearby blood vessels, ensuring a safe and complete removal.
A pancreatic pseudocyst is a localized collection of fluid, pancreatic enzymes, and tissue debris that forms in or around the pancreas, usually following an episode of acute or chronic pancreatitis. While many resolve spontaneously, internal drainage is required for those that become large, painful, or infected.
The Procedure: Internal drainage involves creating a permanent connection (anastomosis) between the pseudocyst and a neighboring digestive organ, allowing the fluid to drain continuously into the gastrointestinal tract.
Cystogastrostomy: This is the most common approach for cysts located directly behind the stomach. A connection is created between the cyst and the stomach wall, allowing the fluid to drain into the stomach.
Cystojejunostomy: For cysts that cannot be easily reached through the stomach, a loop of the jejunum (small intestine) is brought up and connected to the cyst (often using a Roux-en-Y configuration).
Clinical Advantage: Unlike external drains (which carry a risk of infection and skin irritation), internal drainage is a definitive solution that eliminates the need for an external collection bag and utilizes the body's natural digestive pathways.